An adenoviral vector carrying a 2-Kb fragment of the K-ras proto-oncog
ene inserted in antisense orientation with respect to the cytomegalovi
rus promoter was constructed and used to infect H460a lung cancer cell
s (codon 61 K-ras mutation). The gene was efficiently transferred, and
a high level of expression of antisense K-ras was achieved. At a mult
iplicity of infection to achieve 65% transduction of cells, the expres
sion of K-ras protein was reduced by 70% in the lung cancer cell line
H460a as compared with cells infected with control vectors or noninfec
ted cells. This reduction produced a 47% inhibition of monolayer growt
h and a 90% inhibition of colony formation. At a similar level of tran
sduction in the cell line H358 (codon 12 K-ras mutation), a 59% inhibi
tion of monolayer growth compared with control vectors occurred; howev
er the inhibition of H322 cells (wild-type k-ras) growth was no differ
ent than control vector infected cells. These data suggest that the ad
enoviral K-ras H322a antisense vector may have therapeutic potential i
n tumors in which K-ras is mutated.